Lauren Dembeck, PhD

Contributing Writer https://www.hematologyadvisor.com

Lauren Dembeck is a freelance science and medical writer and a contributing author for the Haymarket Medical Network. She holds a BS in biology and a BA in foreign languages from West Virginia University and a PhD in genetics from North Carolina State University. Prior to freelance writing, Lauren was a postdoctoral researcher at the Okinawa Institute of Science and Technology in Japan, where she studied developmental neurobiology. You can find more of her writing at https://laurendembeck.com/.

All articles by Lauren Dembeck, PhD

Myelodysplastic Syndromes

Novel Therapies Needed: Poor Prognosis of Patients With TP53-Mutated Myeloid Malignancies

Lauren Dembeck, PhD

May 26, 2020

Novel treatment options are needed to improve outcomes for patients with TP53</i-mutated myeloid neoplasms.

Thalassemias

Promising New Noninvasive Test Developed for β-Thalassemia in At-Risk Pregnancies

By

Lauren Dembeck, PhD

Publish Date May 26, 2020

Compared to invasive prenatal diagnosis, a noninvansive assay may be a viable alternative for genotyping a fetus in pregnancy at high-risk for β-thalassemia.

Myelodysplastic Syndromes

Prognostic Value of Immunomodulator in Higher-Risk Myelodysplastic Syndromes Treated With Azacitidine

By

Lauren Dembeck, PhD

Publish Date May 22, 2020

Immunomodulator indoleamine-2,3-dioxygenase may be a promising predictor and therapeutic target for patients with higher-risk myelodysplastic syndromes.

General Hematology

Epidemiologic, Clinical, and Laboratory Findings in Cold Agglutinin Disease

By

Lauren Dembeck, PhD

Publish Date May 21, 2020

Researchers assessed data from patients with CAD with the aim of providing information on real-world, long-term outcomes of previously studied therapies.

Myeloma

Steady Improvements in the Survival of Norwegian Patients With Multiple Myeloma

By

Lauren Dembeck, PhD

Publish Date May 21, 2020

Researchers reported significant improvements in 5-year relative survival among older patients with multiple myeloma who were diagnosed from 1982 to 2017.

General Hematology

Laboratory Predictors of Severe Illness and Mortality in COVID-19

By

Lauren Dembeck, PhD

Publish Date May 7, 2020

Investigators recommend that clinicians monitor WBC, lymphocyte, and platelet counts, as well as IL-6 and serum ferritin, in hospitalized COVID-19 patients with respiratory distress.

Thrombotic Disorders

Patterns of Anticoagulant Therapy Use for Acute Venous Thromboembolism

By

Lauren Dembeck, PhD

Publish Date May 5, 2020

Investigators compared the use of DOACs with traditional therapies in patients with acute VTE who were either discharged directly from the ED or hospitalized.

Thrombotic Disorders

High Incidence of Thrombotic Complications in Patients With COVID-19

By

Lauren Dembeck, PhD

Publish Date May 5, 2020

Investigators assessed rates of VTE and arterial thrombotic complications in patients admitted to the ICU with COVID-19 infection.

Anemia

Outcomes of Stem Cell Transplantation in Patients With Newly Diagnosed Transformed Fanconi Anemia

By

Lauren Dembeck, PhD

Publish Date May 4, 2020

What factors influence transplant outcomes in patients with FA with marrow failure that develops into MDS and AL?

Thrombotic Disorders

Venous Thromboembolism vs Major Bleeding: Case Fatality Rates of Patients With Cancer Receiving Anticoagulation

By

Lauren Dembeck, PhD

Publish Date May 4, 2020

Case fatality rates may vary among cancer patients with VTE or major bleeding who receive anticoagulant treatments.

Page 1 of 13
Page 1 Page 2 Page 3 … Page 13 Next page Last page

Popular

Emailed

Recent

Loading...

Loading...

Loading...

Next post in Thrombotic Disorders

Bleeding Risk Assessed With Concomitant Direct Oral Anticoagulants and Verapamil or Diltiazem